The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

INTRODUCTION: The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) ≥ 8.0 mg/dL in a six-month trial. METHODS: Subjects (n = 2,269) were randomized to febuxostat 40 mg or 80 mg, or allopurinol...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Becker, Michael A, Schumacher, H Ralph, Espinoza, Luis R, Wells, Alvin F, MacDonald, Patricia, Lloyd, Eric, Lademacher, Christopher
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888216/
https://ncbi.nlm.nih.gov/pubmed/20370912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2978
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki